CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

Researchers at Northwestern University have built a new type of nanoparticle that triples the efficiency of CRISPR gene ...

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

Trace the timeline of CRISPR-Cas9 from its 2012 discovery to the latest AI-driven advancements and "N-of-1" clinical ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...

Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...

On Tuesday, a federal biosafety and ethics panel gave the go-ahead for the first ever clinical trial using the game-changing gene-editing technology Crispr-Cas9. Scientists at the University of ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

Should we remind ourselves that the Crispr-Cas9 gene-editing tool is still considered an experimental technology? According to a U.S. study, significant and frequent mutations have ...

When applied to human eggs, sperm and embryos, gene-editing technologies, of which CRISPR is the most precise, can alter the ...